Improvements in blood glucose, cholesterol and blood pressure reverse within ~18 months after GLP-1s, versus an estimated ~5 years after behavioural programmes
Significant differences between the two formulations were observed on days 5 and 7 ( p 0.0036), with a maximum circulatory B12 concentration of 454 3.9 pg/mL measured in the Sucrosomial B12 group compared to 274 11.1 pg/mL in the conventional Mecogen SL B12 group on day 5 (Figure 3 boxplots, bottom)
This tool helps you identify your specific wellness goals and provides a personalized routine tailored to your unique needs
10.1186/1471-2377-9-S1-S3 13 BanksW
Nat Commun 11(1):603, 2020
Nausea: Usually mild and short-lived Vomiting and diarrhea: Less frequent but possible, often signifying a need to adjust the dosage Injection site reactions: Redness or irritation at the injection site Low blood sugar: Particularly if combined with other glucose-lowering medications GLP-1 Injections vs